Viking Therapeutics, Inc. (1VT.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 09:29PM CEST
| Previous Close | 69.64 |
| Open | 67.70 |
| Bid | 71.44 x 290000 |
| Ask | 71.88 x 280000 |
| Day's Range | 66.70 - 72.14 |
| 52 Week Range | 8.62 - 91.50 |
| Volume | |
| Avg. Volume | 2,277 |
| Market Cap | 7.955B |
| Beta (5Y Monthly) | 1.10 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.89 |
| Earnings Date | Jul 24, 2024 - Jul 29, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20.10 |
Insider MonkeyViking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript April 24, 2024 Viking Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.27. Viking Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Viking […]
- Thomson Reuters StreetEvents
Q1 2024 Viking Therapeutics Inc Earnings Call
Q1 2024 Viking Therapeutics Inc Earnings Call
- GuruFocus.com
Viking Therapeutics Inc (VKTX) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
Explore the pivotal financial outcomes and strategic directions from Viking Therapeutics' first quarter of 2024.
© 2024 Yahoo. All rights reserved.